← back to search

Juan Huang

Management and Science University · MY
Area of research
Materials Chemistry · Information Systems
Research interest
Research interests include Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Higher Education and Teaching Methods, and Alzheimer's disease research and treatments.
h-index
38
citations
4,732
works
260
NIH funding
primary concept
email

Recent publications

Natural bioactive compounds form herbal medicine in Alzheimer's disease: from the perspective of GSK-3β.
2025cited by 3position: contributordoi
Biomaterials in Alzheimer's Disease: An Anti-Neuroinflammatory Perspective.
2025cited by 2position: contributordoi
Inhibiting MARS attenuates hyperhomocysteinemia-associated neurodegeneration in Parkinson's disease
Neuropharmacology 2025cited by 1position: middledoi
Natural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine.
2025cited by 1position: contributordoi
N‐homocysteinylation of DJ‐1 promotes neurodegeneration in Parkinson's disease
Aging Cell 2024cited by 16position: middledoi
Possible opportunities and challenges for traditional Chinese medicine research in 2035.
2024cited by 8position: contributordoi
Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo.
2024cited by 5position: contributordoi
Dendrobine Ameliorates Alzheimer's Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice.
2024cited by 3position: contributordoi
Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments.
2024cited by 3position: contributordoi
Rhein inhibits M1 polarization of BV2 microglia through MAPK/IκB signalling pathway and reduces neurotoxicity caused by neuroinflammation
International Journal of Developmental Neuroscience 2024cited by 2position: middledoi
Renal-protective effects of Chinese medicinal herbs and compounds for diabetic kidney disease in animal models: protocol for systematic review and meta-analysis
Systematic Reviews 2024cited by 2position: middledoi
Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial
Frontiers in Endocrinology 2024cited by 2position: middledoi
The role of AMPKα subunit in Alzheimer's disease: In-depth analysis and future prospects.
2024cited by 2position: contributordoi
Addition of Ostrea rivularis polysaccharides in microneedle loaded with 3-acetylaconitine liposomes enhance analgesic activities and drug delivery properties
International Journal of Biological Macromolecules 2024cited by 1position: middledoi
The role of TREM2 in Alzheimer's disease: from the perspective of Tau.
2023cited by 35position: contributordoi
Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus.
2023cited by 20position: contributordoi
Clinical antidiabetic medication used in Alzheimer's disease: From basic discovery to therapeutics development.
2023cited by 8position: contributordoi
Breast milk jaundice affects breastfeeding: From the perspective of intestinal flora and SCFAs-GPR41/43.
2023cited by 8position: contributordoi
China's drug clinical trial institution record-keeping system: Qualification requirements for PI are the key.
2023cited by 3position: contributordoi
Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25-35)-induced rodent model of Alzheimer's disease.
2022cited by 8position: contributordoi
Tanshinone <i>ΙΙ</i>A-Incubated Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammation of N9 Cells through TREM2 Signaling Pathway.
2022cited by 7position: contributordoi
Endoscope ear pick: An emerging but neglected medical device.
2022cited by 1position: contributordoi
AMPK: A bridge between diabetes mellitus and Alzheimer's disease.
2021cited by 63position: contributordoi
Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
2021cited by 43position: contributordoi
Resveratrol against 6-OHDA-induced damage of PC12 cells via PI3K/Akt.
2021cited by 9position: contributordoi
Icariin protects against sodium azide-induced neurotoxicity by activating the PI3K/Akt/GSK-3β signaling pathway.
2020cited by 12position: contributordoi
METTL3 and ALKBH5 oppositely regulate m<sup>6</sup>A modification of <i>TFEB</i> mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes
Autophagy 2019cited by 537position: middledoi
METTL3 and ALKBH5 oppositely regulate m&lt;sup&gt;6&lt;/sup&gt;A modification of &lt;i&gt;TFEB&lt;/i&gt; mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.
2019cited by 406position: contributordoi
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development.
2019cited by 86position: contributordoi
Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
2019cited by 43position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Zhiyong Zhang · Institute of Geology and Geophysics4 papers (2018–2019)Nanqu Huang · Zunyi Medical University3 papers (2020–2025) · 3 papers (2020–2025)Charlie Changli Xue · Guangzhou University of Chinese Medicine2 papers (2024–2024)Junfei Jin · Medical University of South Carolina2 papers (2018–2019)Yun Luo · South China Agricultural University2 papers (2018–2019) · 2 papers (2024–2025)Meihua Lin · Sun Yat-sen University2 papers (2018–2019)Anthony Lin Zhang · Berkeley College2 papers (2024–2024)Tian Yu · Huizhou Central People's Hospital2 papers (2018–2019)Zhentao Zhang · Binzhou University2 papers (2024–2025)Xusheng Liu · Guangzhou University of Chinese Medicine2 papers (2024–2024)Junhui Chen · Guangzhou University of Chinese Medicine2 papers (2024–2024)Ruobing Wang · Guangzhou University of Chinese Medicine2 papers (2024–2024) · 2 papers (2024–2025)He Huang · Helmholtz Centre for Environmental Research2 papers (2019–2019)Meifang Liu · Guangzhou University of Chinese Medicine2 papers (2024–2024) · 2 papers (2024–2024)Yong Luo · Zunyi Medical University2 papers (2024–2025)Yanwei Xing · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2018–2018)